Hostname: page-component-5c6d5d7d68-wbk2r Total loading time: 0 Render date: 2024-08-17T13:52:51.621Z Has data issue: false hasContentIssue false

P0091 - Sex differences in the outcome of first episode psychosis

Published online by Cambridge University Press:  16 April 2020

A. Catalan
Affiliation:
Deparment of Psychiatry, Cruces Hospital, Barakaldo, Spain
M. Sanchez
Affiliation:
Deparment of Psychiatry, Cruces Hospital, Barakaldo, Spain
R. Segarra
Affiliation:
Deparment of Psychiatry, Cruces Hospital, Barakaldo, Spain
M. Prieto
Affiliation:
Deparment of Psychiatry, Cruces Hospital, Barakaldo, Spain
M. Gutierrez
Affiliation:
Deparment of Psychiatry, Santiago Apostol Hospital, Vitoria, Spain
I. Eguiluz
Affiliation:
Deparment of Psychiatry, Cruces Hospital, Barakaldo, Spain
C. Fernandez
Affiliation:
Postdoctoral Researcher (Work Group for Community Health and Development, Collaborating Centre With WHO), Kansas University, EEUU, Lawrence, KS, USA

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Objective:

Evaluate the sex differences in first episode psychosis.

Methods and material:

We present an open prospective and muti – center study with a follow – up of 2 years in patients with a first psychoses episode. The patients were treated with risperidone and assessments were made in the first month and then every three months for 2 year. Therefore, we used a protocol including the following scales: PANSS, Global Assessment of Functioning scale (GAF-EEAG), CGI, Young mania rating scale, Hamilton scale for the depression, UKU, OCS, Premorbid Adjustment scale (Cannon-Spoor), the Information Subtest (WAIS) and Psychosocial Stress Global Assessment (DSM III R).

Results:

231 patients were included (32.5% women). Males have consistently an earlier onset even after controlling the cofounding factors and poorer premorbid functioning. Women have a shorter DUP, and they are more likely to be married than men and to live with their couples or children. Women have also better adherence to treatment than men. Males don't show differences in negative, positive symptoms or cognitive deficits. There was no difference between the sexes in the dose of the prescribed antipsychotic. There are no clear sex differences in family history and obstetric complications. Sex doesn't have influence on the course of illness in middle-term (2 years).

Conclusion:

This paper supports the presence of significant differences between schizophrenic males and women, but there aren't differences in the outcome of the disease.

Type
Poster Session I: Schizophrenia and Psychosis
Copyright
Copyright © European Psychiatric Association 2008
Submit a response

Comments

No Comments have been published for this article.